Furthermore, pharmacologic inhibition of NF‐κB activation (BAY11‐7085) dampened the IL‐1β‐induced upregulation of PD‐L1 transcription in all three tumor cell lines, while ERK inhibition (SCH772984) did not work (Figure 3D–F). Here, NFKB1 is linked to neoplasm.